Market Cap 20.53B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 30.08
Forward PE 26.01
Profit Margin -27.97%
Debt to Equity Ratio 0.42
Volume 1,157,600
Avg Vol 1,748,016
Day's Range N/A - N/A
Shares Out 152.80M
Stochastic %K 47%
Beta 1.41
Analysts Sell
Price Target $122.74

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
appayip
appayip Jan. 2 at 1:47 PM
$ILMN noone is talking about this stock but. it has two potential nvidia kind play. 1. Gen editing, when it starts treating more sicknesses 2. Growing AI based Genetics diagnostics/treatments, cancer etc. in both cases, illumina is the nvidia of genetics sector.
0 · Reply
tievLeaf
tievLeaf Jan. 1 at 5:32 AM
$QSI nuff said, just hold. This is the biggest play in the proteomic field with practically low risk at this current price point lol. If u missed quantum, missed ai and missed the space race, this is one i would hold early and dearly onto. 2026 is a BIG year for them. $ILMN $RKLB $POET $RGTI
2 · Reply
N0Bounds
N0Bounds Dec. 31 at 10:39 PM
SNSE is the Next big Retail Squeeze!! $UL $ILMN $GORO $PSTV $BP V
0 · Reply
tievLeaf
tievLeaf Dec. 31 at 3:09 PM
$QSI absolutely insane steal at this price, anyone not loading up is a fucking idiot. Technicals and anything else doesn't even matter at this point when 20 protein coverage with PTM included and proteus is on development timeline and set to release in 2026. More importantly, zoom out the chart even to all time, this stock typically rebounds above $1 strongly over the years. For biotech stocks, this is the biggest biggest bet imo considering how it literally always shows a pattern of going from $1 to $3 and then $3 back to $1 and so on but 2026 is proteus and quite frankly, it might go from $1 to above $5 and who knows where at that point. $NVDA $ILMN, $TMO $UNH
1 · Reply
Arunas1
Arunas1 Dec. 30 at 4:33 PM
Awful looking set ups today $GILD $BMY $ILMN $DIA & $IWM
0 · Reply
Dafy
Dafy Dec. 26 at 5:36 PM
0 · Reply
GenusGains
GenusGains Dec. 25 at 12:16 PM
$ILMN Expectations are shifting from future promises toward demonstrated capability. Progress needs to be observable in both leading indicators and reported metrics. Any disconnect between guidance and results will be magnified by sentiment. From here, delivery cadence—not ambition—will define investability.
0 · Reply
Stanleydavidson
Stanleydavidson Dec. 24 at 4:56 PM
$LAB imagine the price when they finalise deal early 2026 with $ILMN Of 425 millllion $
0 · Reply
Daniels_
Daniels_ Dec. 24 at 4:17 PM
$ILMN genomics name stabilizing after long drawdown needs volume
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 3:39 PM
UBS updates rating for Illumina ( $ILMN ) to Neutral, target set at 145 → 98.
0 · Reply
Latest News on ILMN
Illumina To Webcast Upcoming Investor Conference

Dec 16, 2025, 4:05 PM EST - 19 days ago

Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 10:26 PM EDT - 2 months ago

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript


ILMN Stock vs. IQV Stock

Sep 26, 2025, 9:40 AM EDT - 3 months ago

ILMN Stock vs. IQV Stock

IQV


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 4 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL IONS MRNA RGEN


Illumina: The Stock Is Still Undervalued

Aug 4, 2025, 4:23 AM EDT - 5 months ago

Illumina: The Stock Is Still Undervalued


Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 1:25 AM EDT - 5 months ago

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript


Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Jul 17, 2025, 7:45 AM EDT - 6 months ago

Illumina Stock: What Went Wrong And Why It's Best To Stay Away


Illumina Analysts Lower Their Forecasts After Q1 Results

May 12, 2025, 11:28 AM EDT - 8 months ago

Illumina Analysts Lower Their Forecasts After Q1 Results


Illumina: Multiple Headwinds Point To Limited Upside In 2025

May 10, 2025, 10:58 PM EDT - 8 months ago

Illumina: Multiple Headwinds Point To Limited Upside In 2025


Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:01 PM EDT - 8 months ago

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript


Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Mar 27, 2025, 8:35 AM EDT - 10 months ago

Is Illumina Undervalued After An 83% Drop In Its Stock Price?


appayip
appayip Jan. 2 at 1:47 PM
$ILMN noone is talking about this stock but. it has two potential nvidia kind play. 1. Gen editing, when it starts treating more sicknesses 2. Growing AI based Genetics diagnostics/treatments, cancer etc. in both cases, illumina is the nvidia of genetics sector.
0 · Reply
tievLeaf
tievLeaf Jan. 1 at 5:32 AM
$QSI nuff said, just hold. This is the biggest play in the proteomic field with practically low risk at this current price point lol. If u missed quantum, missed ai and missed the space race, this is one i would hold early and dearly onto. 2026 is a BIG year for them. $ILMN $RKLB $POET $RGTI
2 · Reply
N0Bounds
N0Bounds Dec. 31 at 10:39 PM
SNSE is the Next big Retail Squeeze!! $UL $ILMN $GORO $PSTV $BP V
0 · Reply
tievLeaf
tievLeaf Dec. 31 at 3:09 PM
$QSI absolutely insane steal at this price, anyone not loading up is a fucking idiot. Technicals and anything else doesn't even matter at this point when 20 protein coverage with PTM included and proteus is on development timeline and set to release in 2026. More importantly, zoom out the chart even to all time, this stock typically rebounds above $1 strongly over the years. For biotech stocks, this is the biggest biggest bet imo considering how it literally always shows a pattern of going from $1 to $3 and then $3 back to $1 and so on but 2026 is proteus and quite frankly, it might go from $1 to above $5 and who knows where at that point. $NVDA $ILMN, $TMO $UNH
1 · Reply
Arunas1
Arunas1 Dec. 30 at 4:33 PM
Awful looking set ups today $GILD $BMY $ILMN $DIA & $IWM
0 · Reply
Dafy
Dafy Dec. 26 at 5:36 PM
0 · Reply
GenusGains
GenusGains Dec. 25 at 12:16 PM
$ILMN Expectations are shifting from future promises toward demonstrated capability. Progress needs to be observable in both leading indicators and reported metrics. Any disconnect between guidance and results will be magnified by sentiment. From here, delivery cadence—not ambition—will define investability.
0 · Reply
Stanleydavidson
Stanleydavidson Dec. 24 at 4:56 PM
$LAB imagine the price when they finalise deal early 2026 with $ILMN Of 425 millllion $
0 · Reply
Daniels_
Daniels_ Dec. 24 at 4:17 PM
$ILMN genomics name stabilizing after long drawdown needs volume
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 3:39 PM
UBS updates rating for Illumina ( $ILMN ) to Neutral, target set at 145 → 98.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 3:37 PM
UBS has adjusted their stance on Illumina ( $ILMN ), setting the rating to Neutral with a target price of 98 → 110.
0 · Reply
JarvisFlow
JarvisFlow Dec. 24 at 3:32 PM
Baird updates rating for Illumina ( $ILMN ) to Neutral, target set at 105 → 109.
0 · Reply
Stanleydavidson
Stanleydavidson Dec. 24 at 1:03 PM
$LAB $ILMN the deal will close early 2026 !!! Lab will receive almost 1/2 billion for sale of is somalogic departement and concentrate on biotools after $$$
0 · Reply
ModelsX
ModelsX Dec. 23 at 12:07 AM
0 · Reply
erevnon
erevnon Dec. 22 at 1:00 PM
Canaccord Genuity maintains Illumina $ILMN at Hold and raises the price target from $112 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 22 at 12:51 PM
Canaccord Genuity has updated their rating for Illumina ( $ILMN ) to Hold with a price target of 130.
0 · Reply
Helloa11
Helloa11 Dec. 22 at 1:17 AM
$ILMN AI partnership . $150 incoming https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/what-illumina-ilmns-myome-ai-genomics-partnership-means-for
0 · Reply
lucidi
lucidi Dec. 21 at 11:56 PM
$ILMN I like this chart/price action.
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Dec. 21 at 1:25 PM
$ILMN looks so good
3 · Reply
TheClockworkGroup
TheClockworkGroup Dec. 19 at 10:14 PM
$ILMN #NASDAQ | The markets are unpredictable, but with #WaveE, one of our cutting-edge #AI-driven #algorithmic #breakout #daytrading strategies, you too can make calculated trades like a pro! Scalped profits of +$2,606.80 trading #IlluminaInc., $ILMN shares today! Experience 100% automation and compatibility with @MultiCharts, @NinjaTrader, @TradeStation & @TradingView...
0 · Reply
QuantitativeTrading_
QuantitativeTrading_ Dec. 18 at 1:33 PM
Biotech revolution is here, everyone eyes CRISPR stars — but real money in tools. Gold rush: picks and shovels. Biotech "shovels": $ILMN: Sequencing monopoly $TMO: Lab equipment giant $PACB: Long-read leader $DHR: Life science tools $BECT: Diagnostic king
0 · Reply
Latterholt
Latterholt Dec. 16 at 7:45 PM
🎅📈 S&P 500 Santa Rally Track Record Seasonax data going back 95 years shows the Santa Rally has been remarkably consistent. From Dec. 20 to Jan. 4, the S&P 500 has risen ~76% of the time, averaging a +1.7% gain with 72 advances vs 23 declines. Outside of the Great Depression, drawdowns during this window have historically been limited. The strongest Santa Rally on record came in 1991, with the S&P 500 surging nearly 8% into early January. Top Santa Rally stocks over the last 20 years (Dec. 16–31): • $ILMN: 85% win rate, +4% avg return • $CAT: 80% win rate, +1.25% avg return • $JPM: 75% win rate, +1.89% avg return • $FCX: 70% win rate, +3.54% avg return with multiple double-digit runs • $GS: 65% win rate, +2.69% avg return Seasonality isn’t a guarantee, but history shows Santa has delivered more often than not. 🎄📊
0 · Reply